Furthermore, GR may function similarly in other endocrine-related and/or highly metastatic forms of neoplasia since GR is a widely distributed steroid hormone receptor present in various malignancies such as prostate cancer, ovarian cancer, and melanoma83. Here, NR3C1 is linked to prostate carcinoma.